CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the sale of a Helicos™ Genetic Analysis System to an undisclosed biotechnology company in the Northeast.
